Back to Search
Start Over
Angiogenic Capacity of Periodontal Ligament Stem Cells Pretreated with Deferoxamine and/or Fibroblast Growth Factor-2.
- Source :
-
PloS one [PLoS One] 2016 Dec 09; Vol. 11 (12), pp. e0167807. Date of Electronic Publication: 2016 Dec 09 (Print Publication: 2016). - Publication Year :
- 2016
-
Abstract
- Periodontal ligament stem cells (PDLSCs) represent a good source of multipotent cells for cell-based therapies in regenerative medicine. The success rate of these treatments is severely dependent on the establishment of adequate vasculature in order to provide oxygen and nutrients to the transplanted cells. Pharmacological preconditioning of stem cells has been proposed as a promising method to augment their therapeutic efficacy. In this study, the aim was to improve the intrinsic angiogenic properties of PDLSCs by in vitro pretreatment with deferoxamine (DFX; 100μM), fibroblast growth factor-2 (FGF-2; 10ng/mL) or both substances combined. An antibody array revealed the differential expression of several proteins, including vascular endothelial growth factor (VEGF) and placental growth factor (PlGF). ELISA data confirmed a 1.5 to 1.8-fold increase in VEGF for all tested conditions. Moreover, 48 hours after the removal of DFX, VEGF levels remained elevated (1.8-fold) compared to control conditions. FGF-2 and combination treatment resulted in a 5.4 to 13.1-fold increase in PlGF secretion, whereas DFX treatment had no effect. Furthermore, both PDLSCs as pretreated PDLSCs induced endothelial migration. Despite the significant elevated VEGF levels of pretreated PDLSCs, the induced endothelial migration was not higher by pretreated PDLSCs. We find that the observed induced endothelial cell motility was not dependent on VEGF, since blocking the VEGFR1-3 with Axitinib (0.5nM) did not inhibit endothelial motility towards PDLSCs. Taken together, this study provides evidence that preconditioning with DFX and/or FGF-2 significantly improves the angiogenic secretome of PDLSCs, in particular VEGF and PlGF secretion. However, our data suggest that VEGF is not the only player when it comes to influencing endothelial behavior by the PDLSCs.<br />Competing Interests: All authors have read the journal's policy and declare that there are no competing interests.
- Subjects :
- Adolescent
Adult
Angiogenesis Inducing Agents pharmacology
Animals
Cell Culture Techniques
Cell Movement drug effects
Cells, Cultured
Chickens
Endothelial Cells cytology
Endothelial Cells drug effects
Humans
Young Adult
Deferoxamine pharmacology
Fibroblast Growth Factor 2 pharmacology
Neovascularization, Physiologic drug effects
Periodontal Ligament cytology
Periodontal Ligament drug effects
Stem Cells cytology
Stem Cells drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1932-6203
- Volume :
- 11
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- PloS one
- Publication Type :
- Academic Journal
- Accession number :
- 27936076
- Full Text :
- https://doi.org/10.1371/journal.pone.0167807